Note 3 - Revenue (Tables)

9 Months Ended

Sep. 30, 2022

Notes Tables

Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]

Balance outstanding at December 31, 2021	$	8,698
Increase (decrease) attributed to:
Amounts transferred over time to contract assets		72,536
Amounts invoiced during the period		(71,348	)
Balance outstanding at September 30, 2022	$	9,886

Disaggregation of Revenue [Table Text Block]

	Three Months Ended September 30, 2022
	Product/ Service Transferred Over Time		Product Transferred at Point in Time		Noncash Consideration		Total Net Sales by Market
Medical	$	14,753	$	5,366	$	420	$	20,539
Industrial		8,104		2,314		420		10,838
Aerospace and Defense		3,202		493		204		3,899
Total net sales	$	26,059	$	8,173	$	1,044	$	35,276

	Nine Months Ended September 30, 2022
	Product/ Service Transferred Over Time		Product Transferred at Point in Time		Noncash Consideration		Total Net Sales by Market
Medical	$	37,725	$	15,044	$	1,574	$	54,343
Industrial		21,563		6,301		1,095		28,959
Aerospace and Defense		13,248		1,254		701		15,203
Total net sales	$	72,536	$	22,599	$	3,370	$	98,505

	Three Months Ended September 30, 2021
	Product/ Service Transferred Over Time		Product Transferred at Point in Time		Noncash Consideration		Total Net Sales by Market
Medical	$	13,762	$	2,933	$	282	$	16,977
Industrial		7,468		1,757		158		9,383
Aerospace and Defense		2,883		144		65		3,092
Total net sales	$	24,113	$	4,834	$	505	$	29,452

	Nine Months Ended September 30, 2021
	Product/ Service Transferred Over Time		Product Transferred at Point in Time		Noncash Consideration		Total Net Sales by Market
Medical	$	35,497	$	8,876	$	1,017	$	45,390
Industrial		20,385		4,832		560		25,777
Aerospace and Defense		9,685		527		327		10,539
Total net sales	$	65,567	$	14,235	$	1,904	$	81,706